How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,476 results for

Tocolytic

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. Safety and Efficacy of Albuterol Administered by the Halixâ„¢ Dry Powder Inhaler in Subjects With Asthma

Additional relevant MeSH terms: Layout table for MeSH terms Asthma Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases Albuterol Bronchodilator Agents Autonomic Agents Peripheral Nervous System Agents Physiological Effects of Drugs Anti-Asthmatic Agents Respiratory System Agents Tocolytic Agents Reproductive Control Agents Adrenergic beta-2 Receptor Agonists Adrenergic beta

2018 Clinical Trials

122. A Novel Technique for Prediction of Preterm Birth: Fetal Breathing Patterns

be detected by ultrasonography Condition or disease Intervention/treatment Phase Preterm Birth Device: Fetal nasal Doppler by ultrasonography Not Applicable Detailed Description: Preterm birth refers to a delivery that occurs before 37 weeks of gestation and it is the leading cause of neonatal morbidity and mortality. 33% of prenatal hospital admissions are due to preterm labor but almost 50% of patients receiving tocolytics in order to prevent birth deliver in the term period. Therefore, identification (...) length <20mm Exclusion Criteria: Multifetal pregnancy Cervical dilation > 5 cm Heavy vaginal bleeding Non-reassuring fetal non-stress test Preterm premature rupture of membranes Intrauterine growth restriction Oligohydramniosis Fetal anomaly Patients who received tocolytics for preterm labor or corticosteroids for lung maturation Drug or substance use which may depress fetal breathing Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you

2018 Clinical Trials

123. Nifedipine Metabolism in Pregnancy

terms Hypertension Vascular Diseases Cardiovascular Diseases Nifedipine Calcium Channel Blockers Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Calcium-Regulating Hormones and Agents Physiological Effects of Drugs Vasodilator Agents Tocolytic Agents Reproductive Control Agents

2018 Clinical Trials

124. Uterine Contractions Under Blue Light

warranted by the obstetric provider for proper treatment of preterm labor will be followed. (ie antenatal steroids, tocolytics). Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Estimated Enrollment : 30 participants Allocation: Randomized Intervention Model: Parallel Assignment Intervention Model Description: Randomized clinical trial Masking: Triple (Care Provider, Investigator, Outcomes Assessor) Masking Description: Study group assignments

2018 Clinical Trials

125. Indomethacin for Refractory Chronic Cough

Mechanisms of Pharmacological Action Anti-Inflammatory Agents, Non-Steroidal Analgesics, Non-Narcotic Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Anti-Inflammatory Agents Antirheumatic Agents Gout Suppressants Tocolytic Agents Reproductive Control Agents Cyclooxygenase Inhibitors

2018 Clinical Trials

126. Role of Magnesium in Pediatric Cochlear Implant

Mechanisms of Pharmacological Action Calcium-Regulating Hormones and Agents Tocolytic Agents Reproductive Control Agents

2018 Clinical Trials

127. Impact of Pyloric Injection of Magnesium Sulfate and Lidocaine Mixture on Outcome After Sleeve Gastrectomy

-Arrhythmia Agents Voltage-Gated Sodium Channel Blockers Sodium Channel Blockers Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Analgesics Anticonvulsants Calcium Channel Blockers Calcium-Regulating Hormones and Agents Tocolytic Agents Reproductive Control Agents

2018 Clinical Trials

128. A computational model of excitation and contraction in uterine myocytes from the pregnant rat Full Text available with Trip Pro

in intracellular calcium release) and the tocolytic nifedipine (via a block of L-type calcium channels currents) on action potentials and contractions are also reproduced, which quantitatively match to experimental data. All of these results validated the cell model development. In conclusion, the developed model provides a computational platform for further investigations of the ionic mechanism underlying the genesis and control of electrical and mechanical activities in the rat uterine myocytes.

2018 Scientific reports

129. Effectiveness of nifedipine in threatened preterm labor: a randomized trial Full Text available with Trip Pro

Effectiveness of nifedipine in threatened preterm labor: a randomized trial Threatened preterm labor is a condition in which regular uterine contractions occur at least 1 time in 10 minutes and persist for more than 30 minutes before completion of 37 weeks of gestation without dilatation of the cervix. In preterm labor with cervical dilatation, the efficacy of tocolytics was proven for prolonging pregnancy. However, in threatened preterm labor, the efficacy of tocolytics has not yet been well (...) of treatment, 88.3% of the nifedipine group and 69.9% of the placebo group had no uterine contraction (P<0.001). Nifedipine led to successful treatment outcomes in 77.6% of the total participants compared with 49.5% in the placebo group (P<0.001). The remainder of the participants from both groups needed a second-line tocolytic drug. Of these, 9.7% in the nifedipine group delivered within 48 hours compared with 12.6% in the placebo group (P>0.05). Mean gestation age at delivery and neonatal complications

2018 International journal of women's health Controlled trial quality: predicted high

131. Rupture of a myomectomy site in the third trimester of pregnancy after myomectomy, septoplasty and cesarean section: A case report Full Text available with Trip Pro

, septoplasty and cesarean section. The 39-year-old woman (gravida 2, para 2) presented at 29 weeks' gestation with uterine contractions. She was successfully treated with tocolytics. At 32 weeks of pregnancy, in the absence of contractions, the patient complained of severe abdominal pain and she became hypotensive. Emergency laparotomy and cesarean section were performed, resulting in the delivery of a live infant. The myomectomy site was found to have ruptured but the cesarean and septoplasty scars were

2018 Case Reports in Women's Health

132. Preventing preterm birth: New approaches to labour therapeutics using Nanoparticles. (Abstract)

for the newborn. With private enterprise reluctant to venture into the sphere of tocolysis, due to potential litigation, advances in the field may fall to new approaches using existing tocolytic resources more effectively. An emerging approach is the utilisation of nanoparticles, which have been established as versatile drug carriers with the power to modify the pharmacokinetics of entrapped therapeutics. In this article, we examine the development of nanoparticle-based drug delivery in pregnancy

2018 Best practice & research. Clinical obstetrics & gynaecology

133. Intraperitoneal Bupivacaine With Magnesium or Nalbuphine for Postoperative Pain Control in Laparoscopic Hysterectomy

Anticonvulsants Calcium Channel Blockers Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Calcium-Regulating Hormones and Agents Tocolytic Agents Reproductive Control Agents Analgesics, Opioid Narcotics

2018 Clinical Trials

134. Risk Analysis of Intensive Care Mangement on Maternal and Fetal Outcome of Severe Preeclampsia and Eclampsia

Hypertension Toxemia Hypertension, Pregnancy-Induced Pregnancy Complications Vascular Diseases Cardiovascular Diseases Infection Magnesium Sulfate Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Anesthetics Central Nervous System Depressants Anti-Arrhythmia Agents Anticonvulsants Calcium Channel Blockers Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Calcium-Regulating Hormones and Agents Tocolytic Agents Reproductive Control

2018 Clinical Trials

135. Intra-articular Magnesium Sulfate for Tmj Dysfunction

System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Anesthetics Central Nervous System Depressants Anti-Arrhythmia Agents Anticonvulsants Calcium Channel Blockers Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Calcium-Regulating Hormones and Agents Tocolytic Agents Reproductive Control Agents

2018 Clinical Trials

136. Serum Magnesium Level Administration in Severe Pre-eclampsia Obese Pregnancy

-Eclampsia Hypertension, Pregnancy-Induced Pregnancy Complications Magnesium Sulfate Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Anesthetics Central Nervous System Depressants Anti-Arrhythmia Agents Anticonvulsants Calcium Channel Blockers Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Calcium-Regulating Hormones and Agents Tocolytic Agents Reproductive Control Agents

2018 Clinical Trials

137. Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .

. Singleton pregnancy carrying male fetuses. Gestational age range from 28-34 weeks. Exclusion criteria: Multifetal pregnancy. Hypertension, preterm labor and intrauterine growth restriction. Patients taking a tocolytic agent or those with uterine bleeding at or after blood sampling. Since these complications may increase the level of cell-free fetal DNA. Accidental hemorrhage. Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor

2018 Clinical Trials

138. Magnesium Sulfate in the Prevention of Post-ERCP Pancreatitis.

Pancreatitis Pancreatic Diseases Digestive System Diseases Magnesium Sulfate Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Anesthetics Central Nervous System Depressants Anti-Arrhythmia Agents Anticonvulsants Calcium Channel Blockers Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Calcium-Regulating Hormones and Agents Tocolytic Agents Reproductive Control Agents

2018 Clinical Trials

139. Differences between evidence-based recommendations and actual clinical practice regarding tocolysis: a prospective multicenter registry study. Full Text available with Trip Pro

Differences between evidence-based recommendations and actual clinical practice regarding tocolysis: a prospective multicenter registry study. International guidelines recommend that tocolytic therapy be restricted to a single 48-h application. However, multiple cycles of tocolytic therapy and maintenance therapy that exceeds 48 h appear to play a role in daily clinical practice. We aimed to evaluate current trends in clinical practice with respect to treatment with tocolytic agents (...) and to identify differences between evidence-based recommendations and daily clinical practice in Austria.A prospective multicenter registry study was conducted from October 2013 through April 2015 in ten obstetrical departments in Austria. Women ≥18 years of age who received tocolytic therapy following a diagnosis of threatened preterm birth were included, and details were obtained regarding clinical characteristics, tocolytic therapy, and pregnancy outcome.A total of 309 women were included. We observed

2018 BMC Pregnancy and Childbirth

140. A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic Asthma

, Obstructive Lung Diseases Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases Pharmaceutical Solutions Albuterol Benzalkonium Compounds Bronchodilator Agents Autonomic Agents Peripheral Nervous System Agents Physiological Effects of Drugs Anti-Asthmatic Agents Respiratory System Agents Tocolytic Agents Reproductive Control Agents Adrenergic beta-2 Receptor Agonists Adrenergic beta-Agonists Adrenergic Agonists Adrenergic Agents Neurotransmitter Agents Molecular

2018 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>